Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 15, 2024
Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial
Ying Liu, Jacquelyn Bainbridge, Stefan Sillau, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 17, 2003
Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype
Matthew W State, John M Greally, Adam Cuker, et al.
Pharmaceutics
|
October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant
Fernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
Genome Research
|
October 9, 2002
Draft sequencing and comparative genomics of Xylella fastidiosa strains reveal novel biological insights
Anamitra Bhattacharyya, Stephanie Stilwagen, Gary Reznik, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 17, 2015
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients
Gregory T Everson, Karen D Sims, Paul J Thuluvath, et al.
Gastroenterology
|
August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial
Eric Lawitz, Nancy Reau, Federico Hinestrosa, et al.
Advanced Therapeutics
|
May 17, 2021
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates
Fernanda P Pons-Faudoa, Antons Sizovs, Kathryn A Shelton, et al.
Hepatology (Baltimore, Md.)
|
January 24, 2015
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
David R Nelson, James N Cooper, Jacob P Lalezari, et al.
Cerebellum (London, England)
|
January 2, 2024
The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias
Louisa P Selvadurai, Susan L Perlman, Tetsuo Ashizawa, et al.
Brain : a Journal of Neurology
|
October 28, 2025
Predictive models for ataxia progression and conversion in spinocerebellar ataxia type 1 and 3
Emilien Petit, Giulia Coarelli, David Morgan, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 15, 2024
Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial
Ying Liu, Jacquelyn Bainbridge, Stefan Sillau, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 17, 2003
Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype
Matthew W State, John M Greally, Adam Cuker, et al.
Pharmaceutics
|
October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant
Fernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
Genome Research
|
October 9, 2002
Draft sequencing and comparative genomics of Xylella fastidiosa strains reveal novel biological insights
Anamitra Bhattacharyya, Stephanie Stilwagen, Gary Reznik, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 17, 2015
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients
Gregory T Everson, Karen D Sims, Paul J Thuluvath, et al.
Gastroenterology
|
August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial
Eric Lawitz, Nancy Reau, Federico Hinestrosa, et al.
Advanced Therapeutics
|
May 17, 2021
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates
Fernanda P Pons-Faudoa, Antons Sizovs, Kathryn A Shelton, et al.
Hepatology (Baltimore, Md.)
|
January 24, 2015
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
David R Nelson, James N Cooper, Jacob P Lalezari, et al.
Cerebellum (London, England)
|
January 2, 2024
The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias
Louisa P Selvadurai, Susan L Perlman, Tetsuo Ashizawa, et al.
Brain : a Journal of Neurology
|
October 28, 2025
Predictive models for ataxia progression and conversion in spinocerebellar ataxia type 1 and 3
Emilien Petit, Giulia Coarelli, David Morgan, et al.
Page
of 4